SEMA4D and myeloid sarcoma: Because Sema3A and Sema4D have been suggested to play a role in the pathogenesis of MS and are expressed within MS plaques (Williams et al., 2007), we demonstrated that this antibody did not cross-react with these related semaphorin proteins on a native protein immunoblot (Figure 5(b)).